A monoclonal antibody approach was used to characterize islet cell dif
ferentiation antigens involved in autoimmunity related diabetes mellit
us. This procedure yielded islet cell monoclonal antibodies (ICMAbs)th
at demonstrated varying tissue/cellular distribution. The ICMAb I-45 s
howed a pan-islet reactivity similar to the reactivity of islet cell a
utoantibodies. The target antigen of the ICMAb I-45 demonstrated a neu
roendocrine distribution. Single step immunoaffinity purification of I
-45 antigen using I-45 monoclonal antibody immunoaffinity matrix yield
ed a 68kD protein. The specificity of the immunoaffinity purified 68kD
protein was further demonstrated by the lack of binding of this prote
in to immunoaffinity columns of irrelevant monoclonal antibodies. The
neuroendocrine distribution of the I-45 antigen, like that of other di
fferentiation molecules like HISL-19, neuron specific enolase and chro
mogranin A strengthens the hypothesis of neuroectodermal origin of the
islets of Langerhans.